Harmony Delivery Catheter System (HARMONY-DCS)
Medtronic, Inc. · Decision date Feb 11, 2026
What did the FDA decide?
FDA records P200046/S046 as a supplement to PMA P200046, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Feb 11, 2026.
FDA approval order statement
an additional, alternative external Process Challenge Device (ePCD) for routine monitoring of the ethylene-oxide-sterilization process and reduction the incubation time of the proposed ePCD from the standard 7 days to 4 days
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Feb 11, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P200046/S046
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic, Inc.
- Product code
- NPV
- Decision code
- OK30
- Decision date
- Feb 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Pulmonary valve prosthesis percutaneously delivered.
- Applicant
- Medtronic, Inc.
- Product code
- NPV
- FDA device class
- f
For the original device and its historical approval scope, see PMA P200046. Subsequent supplements may change the device or its indications.
FDA decision timeline
P200046 · Original PMA
Harmony TPV System
P200046/S043 · Related supplement
Harmony TPV System
P200046/S044 · Related supplement
Harmony Transcatheter Pulmonary Valve
P200046/S046 received
Application receipt date recorded by FDA.
P200046/S047 · Related supplement
Harmony Transcatheter Pulmonic Valve System
P200046/S049 · Related supplement
Harmony Transcatheter Pulmonary Valve
P200046/S046 · FDA decision
30-Day Notice
P200046/S045 · Related supplement
Harmony Transcatheter Pulmonary Valve
P200046/S048 · Related supplement
Harmony TPV System
P200046/S050 · Related supplement
Harmony Transcatheter Pulmonary Valve System
P200046/S051 · Related supplement
Harmony Transcatheter Pulmonary Valve
P200046/S052 · Related supplement
Harmony TPV System
Timeline entries are records held by MedtechLedger for P200046. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200046
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Harmony TPV SystemP200046 | Medtronic, Inc. | PMA approval | Mar 26, 2021 | FDA |
Harmony TPV SystemP200046/S043 | Medtronic, Inc. | PMA supplement | Sep 5, 2025 | FDA |
Harmony Transcatheter Pulmonary ValveP200046/S044 | Medtronic, Inc. | PMA supplement | Oct 23, 2025 | FDA |
Harmony Transcatheter Pulmonic Valve SystemP200046/S047 | Medtronic, Inc. | PMA supplement | Jan 16, 2026 | FDA |
Harmony Transcatheter Pulmonary ValveP200046/S049 | Medtronic, Inc. | PMA supplement | Feb 10, 2026 | FDA |
Harmony Transcatheter Pulmonary ValveP200046/S045 | Medtronic, Inc. | PMA supplement | Feb 12, 2026 | FDA |
Harmony TPV SystemP200046/S048 | Medtronic, Inc. | PMA supplement | Mar 6, 2026 | FDA |
Harmony Transcatheter Pulmonary Valve SystemP200046/S050 | Medtronic, Inc. | PMA supplement | Mar 24, 2026 | FDA |
Harmony Transcatheter Pulmonary ValveP200046/S051 | Medtronic, Inc. | PMA supplement | Jun 1, 2026 | FDA |
Harmony TPV SystemP200046/S052 | Medtronic, Inc. | PMA supplement | Sep 30, 2026 | FDA |
Explore the linked device profile
Other records with product code NPV
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 27, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Sep 23, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Jul 29, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Jul 28, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 3576 Unocal Pl., Bldg. A, Santa Rosa, CA, 95403
Sources and methodology
- Original FDA record: P200046/S046
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



